Cintia Piccina Adaptimmune Therapeutics PLC (ADAP) insider trading activity

ADAP Quotes by TradingView

Cintia Piccina is Chief Commercial Officer of Adaptimmune Therapeutics PLC. Currently has a direct ownership of 18,421 shares of ADAP, which is worth approximately $10,868. The most recent transaction as insider was on Jan 15, 2025, when has been sold 12,991 shares (American Depositary Shares representing Ordinary Shares) at a price of $0.57 per share, resulting in proceeds of $7,404. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.4K
51.89% 3M change
5.7% 12M change
Total Value Held $10,868

Cintia Piccina Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 15 2025
SELL
Open market or private sale
$7,404 $0.57 p/Share
12,991 Reduced 41.36%
18,421 American Depositary Sh...
Jun 18 2024
SELL
Open market or private sale
$22,813 $0.93 p/Share
24,531 Reduced 39.05%
38,293 American Depositary Sh...
Jan 31 2023
SELL
Open market or private sale
$22,234 $1.87 p/Share
11,890 Reduced 37.84%
19,535 American Depositary Sh...
Aug 01 2022
SELL
Open market or private sale
$37,241 $1.77 p/Share
21,040 Reduced 37.66%
34,824 American Depositary Sh...

Also insider at

ALVR
Allovir, Inc. Healthcare
Chief Commercial Officer
CP

Cintia Piccina

Chief Commercial Officer
Abingdon, X0

Track Institutional and Insider Activities on ADAP

Follow Adaptimmune Therapeutics PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADAP shares.

Notify only if

Insider Trading

Get notified when an Adaptimmune Therapeutics PLC insider buys or sells ADAP shares.

Notify only if

News

Receive news related to Adaptimmune Therapeutics PLC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADAP